GI & Endoscopy

There is not enough data to recommend fecal microbiota transplant as a treatment for inflammatory bowel disease, according to a study in Current Opinion in Gastroenterology.

Here are 15 things to know about income, net worth, starting salary, payer models and jobs for GI physicians.

The 2017 American Gastroenterological Association research funding portfolio for young investigators has added two more research awards.

Michael Phalen, executive vice president and group president at Boston Scientific, sold 35,000 shares of the company, according to a Press Telegraph report.

The Marshall University Joan C. Edwards School of Medicine in Huntington, W.Va., welcomed gastroenterologist L. Eric Carter, DO, as an assistant professor of medicine, according to a Huntington News report.

Here are four recent news updates on key gastroenterology and endoscopy companies.

JP Morgan initiated coverage on EndoChoice's stock, according to a Trade Calls report.

A study, published in The American Journal of Gastroenterology, identified risk factors associated with early failure of fecal microbiota transplant in the treatment of recurrent or refractory Clostridium difficile infection.

Payers are increasingly reimbursing hospitals for becoming more efficient while maintaining quality. In a value-based payment model, patient outcomes are of the utmost importance, and hospitals failing to maintain infection compliance may suffer financial consequences. BioFire created the FilmArray Gastrointestinal…

Antibe Therapeutics named Yung Wu to its board of directors and completed enrollment for its phase 2 clinical trial.